Skip to content

Effect of sevoflurane preconditioning on autophagy in ischemia/hypoxic lung

Effect of sevoflurane preconditioning on autophagy in ischemia/hypoxic lung

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-15007393
Enrollment
Unknown
Registered
2015-11-08
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung tumor

Interventions

Sevoflurane preconditioning group :Pre inhaled1MAC sevoflurane 30 min
Control group:Oxygen inhalation 30 min

Sponsors

the First Affiliated Hospital,College of Medicine,Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: After Institutional Ethic Committee approval and patient written consent44 patients will be enrolled: 1. age ranging between 18-80 years old; 2. American Society of Anesthesiology (ASA) grade I-III; 3. Scheduled to undergo ectomy lung tumor with double lumen endotracheal intubation general anesthesia.

Exclusion criteria

Exclusion criteria: 1. ASA grade>=III; 2. Cardiac disease such as coronary artery disease,myocardial infarction and arrhythmia; 3. Severe lung disease; 4. Hepatic or renal disease; 5. Pregnant or patients with severe mental illness or non action; 6. The reasons for the disease or the operation can not continue this research; 7. patient refusal.

Design outcomes

Primary

MeasureTime frame
LC3-II;LC3-I;lung injury score;

Secondary

MeasureTime frame
double-lumen endotracheal tube extubate time;the time of chest drainage;Postoperative stay;

Countries

China

Contacts

Public ContactFang Xiangming
xiangming_fang@163.com+86 13857161019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026